These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3366881)
1. Thymic extracellular matrix in myasthenia gravis. II. Immunohistochemical evidence for increased type I collagen degradation. Savino W; Emonard H; Grimaud JA J Neuroimmunol; 1988 Jun; 18(3):223-30. PubMed ID: 3366881 [TBL] [Abstract][Full Text] [Related]
2. Basement membrane proteins and reticulin in a normal thymus and the thymus in myasthenia gravis. Karttunen T Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):245-52. PubMed ID: 2441516 [TBL] [Abstract][Full Text] [Related]
3. Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components. Eimoto T; Kusano T; Ando K; Kikuchi M; Shirakusa T; Kawanami S Am J Clin Pathol; 1990 Jul; 94(1):36-43. PubMed ID: 2193507 [TBL] [Abstract][Full Text] [Related]
4. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis. Aime C; Cohen-Kaminsky S; Berrih-Aknin S J Clin Immunol; 1991 Sep; 11(5):268-78. PubMed ID: 1795043 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic changes of the subseptal thymic epithelium in myasthenia gravis. Savino W; Takacs L; Monostori E; Dardenne M Thymus; 1988-1989; 12(2):111-6. PubMed ID: 2471300 [TBL] [Abstract][Full Text] [Related]
6. Altered intrathymic T-cell repertoire in human myasthenia gravis. Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034 [TBL] [Abstract][Full Text] [Related]
7. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells. Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907 [TBL] [Abstract][Full Text] [Related]
8. NKT-associated markers and perforin in hyperplastic thymuses from patients with Myasthenia gravis. Nagane Y; Utsugisawa K; Obara D; Tohgi H Muscle Nerve; 2001 Oct; 24(10):1359-64. PubMed ID: 11562917 [TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666 [TBL] [Abstract][Full Text] [Related]
10. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis. Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741 [TBL] [Abstract][Full Text] [Related]
11. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis. Utsugisawa K; Nagane Y; Tohgi H Muscle Nerve; 2000 Apr; 23(4):507-13. PubMed ID: 10716760 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix of the human thymus: immunofluorescence studies on frozen sections and cultured epithelial cells. Berrih S; Savino W; Cohen S J Histochem Cytochem; 1985 Jul; 33(7):655-64. PubMed ID: 3891843 [TBL] [Abstract][Full Text] [Related]
13. In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. Emilie D; Crevon MC; Cohen-Kaminsky S; Peuchmaur M; Devergne O; Berrih-Aknin S; Galanaud P Hum Pathol; 1991 May; 22(5):461-8. PubMed ID: 1903354 [TBL] [Abstract][Full Text] [Related]
14. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia. Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356 [TBL] [Abstract][Full Text] [Related]
15. Myoid cells and neuroendocrine markers in myasthenic thymuses. Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292 [TBL] [Abstract][Full Text] [Related]
16. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Meinl E; Klinkert WE; Wekerle H Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of Bcl-2 protein in the myasthenic thymus. Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Cavalcante P; Serafini B; Rosicarelli B; Maggi L; Barberis M; Antozzi C; Berrih-Aknin S; Bernasconi P; Aloisi F; Mantegazza R Ann Neurol; 2010 Jun; 67(6):726-38. PubMed ID: 20517934 [TBL] [Abstract][Full Text] [Related]
19. Thymic histology in myasthenia gravis. Malhotra V; Tatke M; Khanna SK; Gondal R Indian J Chest Dis Allied Sci; 1992; 34(3):117-21. PubMed ID: 1302218 [TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. Sempowski GD; Hale LP; Sundy JS; Massey JM; Koup RA; Douek DC; Patel DD; Haynes BF J Immunol; 2000 Feb; 164(4):2180-7. PubMed ID: 10657672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]